COMMUNIQUÉS West-GlobeNewswire

Optinose CEO Peter Miller and President/COO Ramy Mahmoud Named EY Entrepreneur of the Year 2018 Finalists in the Greater Philadelphia Area
23/04/2018
YARDLEY, Pa., April 23, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that CEO Peter [...]
Nuvectra™ to Report First Quarter 2018 Financial Results on May 2, 2018
23/04/2018
PLANO, Texas, April 23, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today that it will release its financial results for the first quarter ended [...]
Nohla Therapeutics Announces Hiring of Gary Christianson as Chief Operating Officer
23/04/2018
Mr. Christianson Brings More Than 30 Years of Commercial and Operational Expertise SEATTLE, April 23, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a clinical stage biopharmaceutical company focused on the [...]
Probiodrug Appoints Dr. Ulrich Dauer as Chief Executive Officer
23/04/2018
Probiodrug Appoints Dr. Ulrich Dauer as Chief Executive Officer Dr. Ulrich Dauer to team up with Chief Development Officer, Dr. Inge Lues, effective May 1, 2018; Dr. Konrad Glund and Dr. Hendrik Liebers to continue in [...]
Samumed’s Osteoarthritis and Tendinopathy Research Selected for Multiple Presentations at the 2018 Osteoarthritis Research Society International (OARSI) World Congress
23/04/2018
SAN DIEGO, April 23, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, a leader in Wnt research and development, today announced it will present its most recent clinical and preclinical data on the company’s investigational Wnt [...]
Title21 Health Solutions Honored as a ‘Best Place to Work’ for the Second Year in a Row
23/04/2018
Enterprise Healthcare Technology Company, Title21 Health Solutions, was Voted a ‘Best Place to Work’ by the San Francisco Business Times PLEASANTON, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Title21 Health Solutions, “ [...]
Summit Therapeutics plc : Director/PDMR Shareholding
23/04/2018
Summit Therapeutics plc ('Summit' or the 'Company') Exercise of Share Options Oxford, UK, and Cambridge, MA, US, 23 April 2018 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), announces the exercise by the following [...]
Ossur Hf : Transactions in relation to share buyback program
23/04/2018
Announcement no. 30/2018 Reykjavik, 23 April 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
OSE Immunotherapeutics Receives the EuroNext Tech40 Label
23/04/2018
NANTES, France, April 23, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173) (Mnémo:OSE) has received the EuroNext Tech40 Label and is thus admitted to the “Tech40” index. Wanting to give more [...]
Diaxonhit, acteur incontournable du diagnostic in vitro et des sciences de la vie: Résultats annuels 2017
23/04/2018
Résultats annuels 2017 Un nouveau Groupe Acteur incontournable du diagnostic in vitro et des sciences de la vie EBITDA retraité [1] pro forma positif à +0,4 M€ pour l'ensemble de l'exercice 2017, dépassant l'objectif [...]
Shire plc : Holding(s) in Company
23/04/2018
Holding(s) in Company April 23, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : Shire plc (LEI: [...]
Emblem Announces Investment in Fire & Flower
23/04/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, April 23, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) (“ Emblem ” or the “ Company ”), is pleased [...]
Pernix Therapeutics Announces Participation in Lead Bid for Acquisition of Worldwide Rights to Contrave® for Weight Loss
23/04/2018
MORRISTOWN, N.J, April 23, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX ), a specialty pharmaceutical company, today announced that it has agreed to participate in an investor group ( [...]
New Jersey Trying to Ramrod Mandatory Vaccination over Parental Concerns, States the Association of American Physicians and Surgeons (AAPS)
23/04/2018
TUCSON, Ariz., April 23, 2018 (GLOBE NEWSWIRE) -- In a shocking display of arrogance as detailed by Steve Frank , columnist for the Asbury Park Press , a physician-legislator railroaded a bill sharply limiting religious [...]
Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions
23/04/2018
New Indication Expands DCB Treatment for Patients with SFA Lesions Up to 360mm DUBLIN - April 23, 2018 - Medtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval [...]
Nexstim Plc appoints Sisu Partners as new Certified Adviser
23/04/2018
Company announcement, Helsinki, 23 April 2018 at 5:00 PM Nexstim Plc appoints Sisu Partners as new Certified Adviser Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted neuromodulation company [...]
Tabula Rasa Healthcare to Announce First Quarter 2018 Operating Results and Host Conference Call on Tuesday, May 8, 2018
23/04/2018
MOORESTOWN, N.J., April 23, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC ), a healthcare technology company that develops and employs medication risk mitigation software solutions and tools to [...]
Novo Nordisk A/S: Share repurchase programme
23/04/2018
Bagsværd, Denmark, 23 April 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
Immuron’s Travelan® Sales Continue to Soar in Third Quarter of FY2018 in Australian & US Markets
23/04/2018
Key Highlights: US Travelan® sales continue an upward trend with a 95% increase in the Third Quarter of 2018 compared to the same period last year. YTD US sales (End March 2018) climbed to $AUD501K, representing a [...]

Pages